Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-05-21 @ 1:48 PM
Study NCT ID:
NCT05001451
Status:
TERMINATED
Last Update Posted:
2022-07-20
First Post:
2021-07-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of GDX012 in Patients With MRD Positive AML
Sponsor:
GammaDelta Therapeutics Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GDX012U-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None